LUMENIS BE LTD.

Company Snapshot

Entity Type: Private
Employees: 1500
Region: Israel
Headquarter: Yokneam, Isreal
Key Geographics: Israel, Americas, Europe, China, Japan, Asia-Pacific
Corporate Address: Yokneam Industrial Park, Hakidma 9 P.O.B. # 426, Yokneam 2069236 Israel Tel. +972-77-9599000 www.lumenis.com

Company Overview

Lumenis is a leading global manufacturer of energy-based, minimally invasive clinical products for the surgical, ophthalmic and aesthetic markets, including solutions for both medically necessary and elective procedures. Its products include laser, intense-pulsed light and radio-frequency technologies.

Lumenis was the first company to commercially introduce a laser-based product to treat retinal conditions. Its products treat conditions affecting both the anterior and posterior segments of the eye, including various retinal conditions, as well as different types of glaucoma and secondary cataract procedures. The company also distributes a refractive laser solution and is also exploring additional ophthalmic applications with diagnostic capabilities.

For retinal applications, Lumenis’ product solutions provide non-invasive and minimally invasive treatments for conditions such as diabetic retinopathy and retinal detachment. The company also offers systems for refractive surgery, and it pioneered the use of Selective Laser Trabeculoplasty (SLT) in 2001 for the treatment of glaucoma, which has been found to have a success rate of 93% as a primary therapy. The Array LaserLink expands the capabilities of the Lumenis laser system to deliver pattern scanning capabilities, which is designed to provide greater predictability in retinal treatments and less collateral damage to the retina. Array LaserLink is also intended to save treatment time for clinicians and reduce patient discomfort, with shorter pulse duration and sequential multi-spot delivery resulting in shorter laser sessions.

LUMENIS BE LTD. In Reports

Medical Aesthetic Devices: Technologies and Global Markets

BCC Research Report: Dive into medical aesthetic devices market market estimates, data is provided for 2021 and 2022 as historical years, 2023 as the base year, and forecasts extend through 2029.

Eyelid Surgery Blepharoplasty Market

BCC Research Market Report says blepharoplasty market is projected to grow from $3.6 billion in 2022 to $5.4 billion in 2028 at a compound annual growth rate of 6.5% during the forecast period.

Contact Lenses: Technologies and Global Markets

BCC Research Market Report says contact lenses market reached $8.2 bln in 2022 and should reach $11.6 bln by 2027, with a CAGR of 7.1%.

Company's Business Segments

  • Treatments : The company generates revenue from several treatments, such as Facial Muscle Stimulation, Hair Removal, Body, Skin, Photofabulous, SmoothGlo, Pigmentation, Scars, Tattoo Removal, vascular lesions, Women’s Health.
  • Products : The company sells products including triLift, Stellar M22, SPLENDOR X, ULTRApulse Alpha, Legend Pro+, LightSheer QUATTRO, NuEra Tight, AcuPulse, M22, FemTouch.
  • Technologies : The company generates revenue from technologies such as Ablative Lasers CO2, IPL (Intense Pulsed Light), Long Pulsed Nd:YAG, Fractional Non Ablative, Q-Switched Nd:YAG, Diode Lasers, Radio-Frequency (RF), RF Micro-Needling, BLEND X Alex YAG.
  • Eye care solutions : The company offers eye care solutions for Dry Eye, Glaucoma, Retina.

Applications/End User Industries

  • Healthcare
  • Clinics
  • Hospitals